Analysis of TMA and VOD after allogenic stem cell transplantation
Project/Area Number |
19591130
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Hematology
|
Research Institution | Nara Medical University |
Principal Investigator |
MATSUMOTO Masanori Nara Medical University, 医学部, 准教授 (60316081)
|
Co-Investigator(Kenkyū-buntansha) |
FUJIMURA Yoshihiro 奈良県立医科大学, 医学部, 教授 (80118033)
|
Project Period (FY) |
2007 – 2009
|
Project Status |
Completed (Fiscal Year 2009)
|
Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2009: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2008: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2007: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | 造血幹細胞移植学 / TMA / ADAMTS13 / VWF / VOD / 造血幹細胞移植 |
Research Abstract |
Both hepatic veno-occulusive disease (VOD) and thrombotic microangiopathy (TMA) after stem cell transplantation (SCT) are life-threatening thrombotic complications. We demonstrated that prophylactic fresh frozen plasma (FFP) infusion prevented development of hepatic VOD after SCT in a multicenter, randomized trial. Forty-three patients were divided into two groups : 23 receiving FFP infusions and 20 not receiving it VOD developed only in three patients not receiving FFP. Since 1998, our laboratory has functioned as a nationwide referral center for TMA by analyzing ADAMTS13. As the end of 2008, we have established a registry of 919 patients with TMA. Of these, one-third of TMA patients had severe deficiency of ADAMTS13 activity. Fifty-four patients were classified as SCT associated TMA. None of the patients in this category had severe deficiency of ADAMTS13 activity as previously reported.
|
Report
(4 results)
Research Products
(79 results)
-
-
-
-
-
-
[Journal Article] Pregnancy-induced thrombocytopenia and thrombotic microangiopathy in Upshaw-Schulman syndrome: Clinical observations and ADAMTS13 gene analysis in nine patients representing six families.2009
Author(s)
Fujimura Y, Matsumoto M, Kokame K, Isonishi A, Soejima K, Akiyama N, Tomiyama J, Kazuhiko Natori K, Kuranishi Y, Imamura Y, Inoue N, Higasa S, Seike M, Kozuka T, Hara M, Wada H, Murata M, Ikeda Y, Miyata T, George JN
-
Journal Title
Br J Haematol 144
Pages: 742-754
Related Report
-
[Journal Article] Human Placental Ectonucleoside Triphosphate Diphosphohydrolase Gene Transfer via Gelatin-Coated Stents Prevents In-Stent Thrombosis.2009
Author(s)
Takemoto Y, Kawata H, Soeda T, Imagawa K, Somekawa S, Takeda Y, Uemura S, Matsumoto M, Fujimura Y, Jo JI, Kimura Y, Tabata Y, Saito Y
-
Journal Title
Arterioscier Thromb Vase Biol 29
Pages: 857-862
Related Report
-
[Journal Article] The significance of ADAMTSI3 in a patient with thrombotic thrombocytopenic purpura complicated autoimmune hepatitis.2009
Author(s)
Shimizu M, Nomura S, Ishii K, Mohri Y, Umei N, Suzuki S, Matsuo Y, Isonishi A, Matsumoto M, Urase F, Maeda Y, Fujimura Y
-
Journal Title
Thromb Haemost 101
Pages: 599-600
Related Report
-
[Journal Article] Increased production of ADAMTS13 in hepatic stellate cells contributes to enhanced plasma ADAMTS13 activity in rat models of cholestasis and steatohepatitis.2009
Author(s)
Watanabe N, Ikeda H, Kume Y, Satoh Y, Kaneko M, Takai D, Tejima K, Nagamine M, Mashima H, Tomiya T, Noiri E, Omata M, Matsumoto M, Fuiimura Y, Yatomi Y
-
Journal Title
Thromb Haemost 102
Pages: 389-396
Related Report
-
-
[Journal Article] Decreased ADAMTSI3 levels in patients with living donor liver transplantation.2009
Author(s)
Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, Katayama N, Uemoto S, Ishizashi H, Matsumoto M, Fujimura Y, lsaji S
-
Journal Title
Thromb Res 124
Pages: 541-545
Related Report
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis.2008
Author(s)
Uemura M, Fujimura Y, Matsumoto M, Ishizashi H, Kato S, Matsuyama T, Isonishi A, Ishikawa M, Yagita M, Morioka C, Yoshiji H, Tsujimoto T, Kurumatani N, Fukui H
-
Journal Title
Thromb Haemost 99
Pages: 1019-1029
Related Report
-
[Journal Article] Acute Myocardial Infarction as a Systemic Prothrombotic Condition Evidenced by Increased von Willebrand Factor Protein Over ADAMTS13 Activity in Coronary and Systemic Circulation.2008
Author(s)
Horii M, Uemura S, Uemura M, Matsumoto M, Ishizashi H, Imagawa K, Iwama H, Takeda Y, Kawata H, Nakajima T, Fujimura Y, Saito Y
-
Journal Title
Heart and Vessels 23
Pages: 301-307
Related Report
-
[Journal Article] Plasma ADAMTS 13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.2008
Author(s)
Morioka C, Uemura M, Matsuyama T, Matsumoto M, Kato S, Ishikawa M,. Ishizashi H, Fujimoto M, Sawai M, Yoshida M, Mitoro A, Yamao J, Tsujimoto T, Yoshiji H, Urizono Y, Hata M, Nishio K, Okuchi K, Fujimura Y, Fukui H
-
Journal Title
Scand J Gastroenterol 43
Pages: 1387-1396
Related Report
-
-
-
-
-
-
-
-
-
-
[Journal Article] Increased von Willebrand factor over decreased ADAMTS 13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis2007
Author(s)
Matsuyama T, Uemura M, Ishikawa M, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H, Fujimura Y, Fukui H
-
Journal Title
Related Report
-
-
-
-
-
-
[Journal Article] Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: A report from the Surveillance, Epidemiology, and Risk Factors for Thrombotic Thrombocytopenic Purpura (SERF-TTP) research group and the Research on Adverse Drug Events and Reports (RADAR) project.2007
Author(s)
Bennett CL, Banjamin K, Zakarija A, Bandarenko N, Pandey DK, Buffie CG, McKoy JM, Tevar AD, Cursio JF, Yarnold PR, Kwaan HC, De Masi D, Sarode R, Raife TJ, Kiss JE, Raisch DW, Davidson C, Sadler JE, Ortel TL, Zheng XL, Kato S, Matsumoto M, Uemura M, Fujimura Y
-
Journal Title
J Am Coll Cardiol 50
Pages: 1138-1143
Related Report
-
[Journal Article] Prophylactic fresh frozen plasma infusion may prevent the development of hepatic VOD after stem cell transplantation via ADAMTS 13-mediated restoration of von Willebrand factor plasma levels.2007
Author(s)
Matsumoto M, Kawa K, Uemura M, Kato S, Ishizashi H, Isonishi A, Yagi H, Park YD, Takeshima Y, Kosaka Y, Hara H, Kai S, Kanamaru A, Fukuhara S, Hino M, Sako M, Hiraoka A, Ogawa H, Ham J, Fujimura Y
-
Journal Title
Bone Marrow Transplant 40
Pages: 251-259
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Potential role of enhanced cytokinemia and endotoxemia on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis.2008
Author(s)
Masatoshi Ishikawa, Masahito Uemura, Tomomi Matsuyama, Masanori Matsumoto, Masao Fujimoto, Hiromichi Ishizashi, Seiji Kato, Chie Morioka, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Hidehito Kawaratani, Yoshihiro Fujimura, Hiroshi Fukui
Organizer
50th ASH annual meeting
Place of Presentation
San Francisco (USA)
Related Report
-
-
-
-
-
-
[Presentation] Clinical and outcomes findings for thrombotic thrombocytopenic purpura among 467 persons with severely versus not severely deficient ADAMTS-13 levels.2007
Author(s)
Bennett CL, Luu TH, Zakarija A, Kwaan HC, Bandarenko N, Pandey DK, Curio JF, McKoy JM, Buffie C, Winters JL, Ortel TL, Sarode R, Zheng XL, Raife TJ, Matsumoto M, Fujimura Y. Rock GA
Organizer
49th ASH annual meeting
Place of Presentation
Atlanta (USA)
Related Report
-
[Presentation] Ticlopidine- and Clopidogrel- associated thrombotic thrombocytopenic purpura (TTP): final results from the serveillance epidermiology and risk factor- TTP study group.2007
Author(s)
Richey EA, Bennett CL, Kwaan HC, Zakarija A, Bandarenko N, Pandey DK, Yarnold PR, Raisch DW, Winters TL, Raife TJ, Curio JF, Fisher MJ, Ortel TL, Tallman MS, Matsumoto M, Fujimura Y. Moake JL
Organizer
49th ASH annual meeting
Place of Presentation
Atlanta (USA)
Related Report
-
[Presentation] Plasma ADAMTS13 activity markedly decreased in patients with severe acute pancreatitis: Its potential role on the development of multiorgan failure.2007
Author(s)
Morioka C, Uemura M, Matsuyama T, Matsumoto M, Kato S, Ishikawa M, Ishizashi H, Fujimoto M, Tsujimoto T, Nishio K, Okuchi K, Fujimura Y, Fukui H
Organizer
49th ASH annual meeting
Place of Presentation
Atlanta (USA)
Related Report
-
[Presentation] Natural history of 33 patients with Upshaw-Schulman syndrome has revealed that all the gravida develop thrombocytopenia, often followed by thrombotic microangiopathy with stillbirth.2007
Author(s)
Fujimura, Y, Matsumoto M, Kokame K, Yagi H, Isonishi A, Matsuyama T, Kato S, Ishizashi H, Shida Y, Kenji N, Akiyama N, Tomiyama J, Natori K, Kuraishi Y, lmamura Y, Inoue N, Higasa S, Seike M, Kozuka T, Hara M, Sugimoto M, Wada H, Murata M, Miyata T, Ikeda Y
Organizer
49th ASH annual meeting
Place of Presentation
Atlanta (USA)
Related Report
-
-
-
-
-
-
-
-
-